The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9401-9414

  Bae, Ji Eun ^a   Huh, Man Il ^a   Ryu, Byung Kyu ^b   Do, Ji Yeon ^a   Jin, Seong Uk ^a   Moon, Myung Jin ^c   Jung, Jae Chang ^a   Chang, Yongmin ^d   Kim, Eungseok ^e   Chi, Sung Gil ^b   Lee, Gang Ho ^a   Chae, Kwon Seok ^a  

^a Kyungpook National University   (South Korea)

^b Korea University   (South Korea)

^c Dankook University   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

^e Chonnam National University   (South Korea)

Author keywords

Aggregates; Cytotoxicity; Electromagnetic biology; Magnetic nanoparticles; MRI; Static magnetic field

Indexed keywords

ADVERSE EFFECT; APOPTOTIC EFFECTS; BIOMEDICAL APPLICATIONS; CELL CYCLE; CELL VIABILITY; CELLULAR UPTAKE; CYTOTOXICITY ASSESSMENT; GIANT CELLS; HEPATOCYTES; IN-VITRO; LONG TERM MONITORING; MAGNETIC NANOPARTICLES; MODEL SYSTEM; MRI CONTRAST AGENTS; REACTIVE OXYGEN SPECIES; STATIC MAGNETIC FIELDS; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC NANOPARTICLES; SURFACE FABRICATION;

AGGREGATES; BIOCOMPATIBILITY; BIOELECTRIC PHENOMENA; CELL DEATH; CYTOTOXICITY; IRON OXIDES; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; NANOPARTICLES; SUPERPARAMAGNETISM;

NANOMAGNETICS;

CASPASE 3; CASPASE 7; FERUCARBOTRAN; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL CYCLE ARREST; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; ELECTRIC FIELD; GIANT CELL; LIVER CELL; MAGNETIC FIELD; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATIC ELECTRICITY; STATIC MAGNETIC FIELD;

ANIMALS; CELL DEATH; CELL LINE; DEXTRANS; ENDOCYTOSIS; HEPATOCYTES; INTRACELLULAR SPACE; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; REACTIVE OXYGEN SPECIES;

EID: 80053611612     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.075     Document Type: Article

References (43)

1. Hao R., Xing R., Xu Z., Hou Y., Gao S., Sun S. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv Mater 2010, 6(22):2729-2742.
2. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009, 61:467-477.
3. Gandhi S.N., Brown M.A., Wong J.G., Aguirre D.A., Sirlin C.B. MR contrast agents for liver imaging: what, when, how. Radiographics 2006, 26:1621-1636.
4. Morana G., Salviato E., Guarise A. Contrast agents for hepatic MRI. Cancer Imaging 2007, 7:S24-S27.
5. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
6. Xia T., Li N., Nel A.E. Potential health impact of nanoparticles. Annu Rev Pub Health 2009, 30:137-150.
7. Lorusso V., Pascolo L., Fernetti C., Anelli P.L., Uggeri F., Tiribelli C. Magnetic resonance contrast agents: from the bench to the patient. Curr Pharm Des 2005, 11:4079-4098.
8. Latham A.H., Williams M.E. Controlling transport and chemical functionality of magnetic nanoparticles. Acc Chem Res 2008, 41:411-420.
9. Kehagias D.T., Gouliamos A.D., Smyrniotis V., Vlahos L.J. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001, 14:595-601.
10. Lunov O., Syrovets T., Rocker C., Tron K., Nienhaus G.U., Rasche V., et al. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 2010, 31:9015-9022.
11. Johnsen S., Lohmann K.J. The physics and neurobiology of magnetoreception. Nat Rev 2005, 6:703-712.
12. Wiltschko R., Wiltschko W. Magnetoreception. Bioessays 2006, 28:157-168.
13. Feychting M., Ahlbom A., Kheifets L. EMF and health. Ann Rev Pub Health 2005, 26:165-189.
14. Dini L., Abbro L. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 2005, 36:195-217.
15. Evans V.J., Hawkins N.M., Westfall B.B., Earle W.R. Studies on culture lines derived from mouse liver parenchymatous cells grown in long-term tissue culture. Cancer Res 1958, 18:261-266.
16. Park J.Y., Baek M.J., Choi E.S., Woo S., Kim J.H., Kim T.J., et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano 2009, 3:3663-3669.
17. Koh E.K., Ryu B.K., Jeong D.Y., Bang I.S., Nam M.H., Chae K.S. A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species. Int J Radiat Biol 2008, 84:945-955.
18. Chae K.S., Kang M.J., Lee J.H., Ryu B.K., Lee M.G., Her N.G., et al. Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-1 under non-hypoxic conditions. Oncogene 2010, 30:1213-1228.
19. Chae K.S., Dryer S.E. The p38 mitogen-activated protein kinase pathway negatively regulates Ca2+-activated K+ channel trafficking in developing parasympathetic neurons. J Neurochem 2005, 94:367-379.
20. Graham R.C., Karnovsky M.J. The histochemical demonstration of uricase activity. J Histochem Cytochem 1965, 13:448-453.
21. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010, 11:700-714.
22. Smith C.A., de la Fuente J., Pelaz B., Furlani E.P., Mullin M., Berry C.C. The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. Biomaterials 2010, 31:4392-4400.
23. Sherwood L.K.H., Yancey P.H. Animal physiology: from genes to organisms 2005, Brooks/Cole, Cengage Learning, pp. 359-426.
24. Lunov O., Zablotskii V., Syrovets T., Rocker C., Tron K., Nienhaus G.U., et al. Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials 2011, 32:547-555.
25. Tanahashi C., Nagae H., Nukaya T., Hasegawa M., Yatabe Y. Combined hepatocellular carcinoma and osteoclast-like giant cell tumor of the liver: possible clue to histogenesis. Pathol Int 2009, 59:813-816.
26. Soenen S.J., De Cuyper M. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine 2010, 5:1261-1275.
27. Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
28. Cormode D.P., Skajaa G.O., Delshad A., Parker N., Jarzyna P.A., Calcagno C., et al. A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. Bioconjug Chem 2011, 22:353-361.
29. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008, 105:14265-14270.
30. Wiogo H.T., Lim M., Bulmus V., Yun J., Amal R. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 2011, 27:843-850.
31. Barnes A.L., Wassel R.A., Mondalek F., Chen K., Dormer K.J., Kopke R.D. Magnetic characterization of superparamagnetic nanoparticles pulled through model membranes. Biomagn Res Technol 2007, 5:1.
32. Tresilwised N., Pithayanukul P., Mykhaylyk O., Holm P.S., Holzmuller R., Anton M., et al. Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. Mol Pharmacol 2010, 7:1069-1089.
33. Lunov O., Syrovets T., Loos C., Beil J., Delacher M., Tron K., et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 2011, 5:1657-1669.
34. Naqvi S., Samim M., Abdin M., Ahmed F.J., Maitra A., Prashant C., et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomed 2010, 5:983-989.
35. Soenen S.J., Brisson A.R., De Cuyper M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 2009, 30:3691-3701.
36. Malhi H., Guicciardi M.E., Gores G.J. Hepatocyte death: a clear and present danger. Physiol Rev 2010, 90:1165-1194.
37. Grassi-Schultheiss P.P., Heller F., Dobson J. Analysis of magnetic material in the human heart, spleen and liver. Biometals 1997, 10:351-355.
38. Binhi V.N., Chernavskii D.S. Stochastic dynamics of magnetosomes in cytoskeleton. Europhys Lett 2005, 70:850-856.
39. Lunov O., Syrovets T., Buchele B., Jiang X., Rocker C., Tron K., et al. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010, 31:5063-5071.
40. Asanuma T., Ono M., Kubota K., Hirose A., Hayashi Y., Saibara T., et al. Super paramagnetic iron oxide MRI shows defective kupffer cell uptake function in non-alcoholic fatty liver disease. Gut 2010, 59:258-266.
41. Pacchierotti F., Eichenlaub-Ritter U. Environmental hazard in the aetiology of somatic and germ cell aneuploidy. Cytogent Genome Res 2011, 133:254-268.
42. Ahaouche M., Cazals-Hatem D., Sommacale D., Cadranel J.F., Belghiti J., Degott C. A malignant hepatic tumour with osteoclast-like giant cells. Histopathology 2005, 46:590-592.
43. Leikam C., Hufnagel A., Schartl M., Meierjohann S. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene 2008, 27:7070-7082.